Emergency: balversa medication
Ended Awarded Last action
- Contract number
- 36C24122N0082
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $15,091
Award facts
- Contract value 100% obligated
- $15,090.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., to provide BALVERSA (erdafitinib), an oncology medication, to the VA's Veterans Health Administration (VHA). The $15,090.62 delivery order was issued on an emergency basis to the pharmaceutical manufacturer under a $3.7 million Blanket Purchase Agreement (BPA) established in 2020, which allows VHA buying offices to efficiently procure BALVERSA and other oncology drugs through July 2024. Janssen Biotech also holds a $3.1 billion Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs with the VA, which serves as the parent vehicle for many of the company's federal contract awards. This delivery order does not have a set-aside designation, reflecting Janssen's status as a large, for-profit pharmaceutical manufacturer. The contract supports the VA's comprehensive healthcare programs for veterans by ensuring a steady supply of critical oncology medications at VA medical facilities nationwide.
Quick answers
Who was awarded contract 36C24122N0082?
36C24122N0082 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on October 8, 2021.
How much is contract 36C24122N0082 worth?
The government has obligated $15,091 on 36C24122N0082.
Is contract 36C24122N0082 an order under another contract?
Yes. 36C24122N0082 is a BPA call under 36F79719D0217-36E79720A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24122N0082 competed?
The extent of competition for 36C24122N0082 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award